Literature DB >> 3137305

Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes.

R L Medcalf1, E K Kruithof, W D Schleuning.   

Abstract

Human rTNF/Cachectin was shown to stimulate gene transcription of plasminogen activator inhibitor (PA1)-1 and PAI-2, and simultaneously suppress constitutive gene expression of tissue-type plasminogen activator (t-PA) in human fibrosarcoma cells. We propose that a TNF-mediated reprogramming of gene transcription induces, in appropriate target cells, an anti-fibrinolytic state, which may cooperate with the induction of procoagulant activity (tissue factor) to stabilize the fibrin deposits commonly found in inflamed tissue. PAI genes also provide a model system for a study of the molecular pathways underlying TNF-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3137305      PMCID: PMC2188989          DOI: 10.1084/jem.168.2.751

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

Review 2.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

3.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.

Authors:  M E Greenberg; E B Ziff
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

5.  Number and organization of actin-related sequences in the mouse genome.

Authors:  A J Minty; S Alonso; J L Guénet; M E Buckingham
Journal:  J Mol Biol       Date:  1983-06-15       Impact factor: 5.469

6.  A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia.

Authors:  F M Torti; B Dieckmann; B Beutler; A Cerami; G M Ringold
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

7.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

Authors:  D J Loskutoff; J A van Mourik; L A Erickson; D Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

8.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

9.  Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region.

Authors:  R Fisher; E K Waller; G Grossi; D Thompson; R Tizard; W D Schleuning
Journal:  J Biol Chem       Date:  1985-09-15       Impact factor: 5.157

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Cytokine-mediated proteolysis in tissue remodelling.

Authors:  S Masure; G Opdenakker
Journal:  Experientia       Date:  1989-06-15

2.  Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.

Authors:  M E Meltzer; S J Hasstedt; C Y Vossen; P W Callas; Ph G DE Groot; F R Rosendaal; T Lisman; E G Bovill
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

3.  Short-chain fatty acids induce tissue plasminogen activator in airway epithelial cells via GPR41&43.

Authors:  Y Imoto; A Kato; T Takabayashi; M Sakashita; J E Norton; L A Suh; R G Carter; A R Weibman; K E Hulse; W Stevens; K E Harris; A T Peters; L C Grammer; B K Tan; K Welch; D B Conley; R C Kern; S Fujieda; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2018-03-24       Impact factor: 5.018

4.  Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.

Authors:  R Lucas; K Heirwegh; A Neirynck; L Remels; H Van Heuverswyn; P De Baetselier
Journal:  Immunology       Date:  1990-10       Impact factor: 7.397

Review 5.  Tumor necrosis factor: an update on basic research and clinical applications.

Authors:  M Schleuning; R Munker
Journal:  Klin Wochenschr       Date:  1990-09-03

6.  Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infection.

Authors:  Isis K Mullarky; Frank M Szaba; Kiera N Berggren; Lawrence W Kummer; Lindsey B Wilhelm; Michelle A Parent; Lawrence L Johnson; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease.

Authors:  A Estellés; S Grancha; J Gilabert; T Thinnes; M Chirivella; F España; J Aznar; D J Loskutoff
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

8.  Increased levels of plasminogen activator inhibitor-1 (PAI-1) in human brain tumors.

Authors:  J S Rao; A Rayford; R A Morantz; B W Festoff; R Sawaya
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

9.  Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.

Authors:  P G Tipping; P Davenport; M Gallicchio; E L Filonzi; J Apostolopoulos; J Wojta
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

10.  Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter.

Authors:  E Cousin; R L Medcalf; G E Bergonzelli; E K Kruithof
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.